Investor Ideas #Potcasts; #Cannabis News and #Stocks on the Move: Interview with David Metzler, CEO of CBD Capital Group
Delta, Kelowna, BC –October 9, 2019 (Investorideas.com Newswire) www.Investorideas.com, a global news source covering leading sectors including marijuana and hemp stocks and its potcast site, www.potcasts.ca release today’s edition of Investorideas.com potcastsCM - cannabis news and stocks to watch plus insight from thought leaders and experts.
Listen to the podcast:
Read this in full at https://www.investorideas.com/news/2019/cannabis-potcasts/10091Interview-DavidMetzler-CBDCapitalGroup.asp
In today’s podcast I interview David Metzler, CEO of CBD Capital Group, where we discussed how CBD Capital Group best assesses their companies in the CBD space as well as current trends in the CBD market.
When asked how CBD Capital Group assesses companies within the CBD market, David went on to explain some of the key factors they look at first. “We’ve looked, since we started a year ago, at probably 45 companies and have put out 4 term sheets out, did our first deal in April of 2019 and in August we got out second deal lined up and are closing that now. We have a fairly deep understanding of the marketplace. One of the easiest properties to figure out success is just revenue, but we believe that’s not enough. We look at a couple different things in our evaluation framework. We look at what is unique about the product, what is the product quality like and then we look deeply into the supply chain. We have relationships within the supply chain, so if we’re not satisfied with company but their revenue and customer support systems are there, we can apply our expertise to help them redo their supply chain and get high quality CBD with better potency and quality. The other factors for us are competency of manufacturing and delivery of the product to the customers, so we go pretty deeply into the customer experience.”
David also went on to discuss how they look at the different forms of CBD, whether it is CBD isolate, full spectrum or broad spectrum and where he sees the market heading. “We’re not doing isolate anymore. One of our board members is part of the Hemp Round Table, and if you’re on the inside track and watching what the FDA is going to be doing in the next quarter, most everyone agrees that isolate is going to end up in the pharmaceutical grade, and thereby cut off from mass consumption and have patents involved, with GW Pharmaceuticals being the leader in that. So we believe in full-spectrum CBD. The isolate also adds a lot of chemicals into the product. So broad spectrum and full spectrum are where we are focussing, we’re sourcing from \Kentucky and we know exactly where the farms are.”
David also went on to discuss the SAFE Banking Act and how that will affect the industry as well as the ways his company has looked to address these banking issues early on. “We realized before we started CBD Capital Group, that merchant processing was going to a problem for a long period of time going forward. Even with the Farm Bill passed last September, it is still almost a year later. The SAFE Banking Act is going to help a lot there. But what we’ve decided to do was focus on relationships. So all of the companies that we’ve bought and are buying, we have a company in the space and they are processing at below market rates for us. We created that relationship early on so that none of our companies and our money is at risk because we are using this merchant processing solution. For the industry as a whole, there’s companies paying 5% to 6% for merchant processing. Our rates are sub 3, so that’s a huge advantage that we have and our companies have. We’re still super excited that the SAFE Banking Act will pass, because it will only mean that more banks will open up and more banks in the space means that more institutional capital will come into the space.”
David went on to discuss some of the investor trends he and CBD Capital Group have noticed in the market so far as well as some of the largest red flags and opportunities to be aware of moving forward in the industry.
CBD Capital Group announced back in July that it had acquired Medix CBD, a natural medicine and wellness company.
“After evaluating the potential of many U.S.-based cannabidiol (CBD) brands, we are proud to announce the acquisition of Medix CBD for a multitude of reasons including profitability, the company’s unique SEO model and a strong founding story that aligns with our values,” said CBD Capital Group Co-Founder and CEO David Metzler. “We look forward to growing alongside Medix CBD as we combine our ability to raise capital and business guidance with the company’s vast potential and high-quality offerings.”
The CBD Capital Group management team has created or managed over $1 billion over the course of their combined careers. The Company’s primary goal is to become an attractive acquisition target or IPO at a $400 million to $800 million valuation. CBD Capital Group plans to achieve this by acquiring profitable CBD companies ranging from $1 million to $10 million in annual revenue. Though these lifestyle companies typically have limited exit opportunities by themselves, their combined value is highly attractive to mega brands, Private Equity (PE) firms, or in an IPO. After each acquisition, CBD Capital Group supports these businesses and their respective existing leadership teams through expertise in operations, recruiting, finance, marketing, supply chain optimization, retail distribution, and legal strategy.
Investor ideas reminds all listeners to read our disclaimers and disclosures on the
Investorideas.com website and this podcast is not an endorsement to buy products or services or securities. Investors are reminded all investment involves risk and possible loss of investment
Subscribe to the new cannabis podcast series:
Investorideas.com podcasts are also available on iTunes, Spotify, Google Play Music, Stitcher, Spreaker, YouTube via Spreaker, iHeartradio and Tunein.
Potcasts is now a certified word mark Trademark on the blockchain through Cognate, Inc. CM Certification-Registration Number: 10468217708
About Investorideas.com - News that Inspires Big Investing Ideas Investorideas.com is a recognized news source publishing third party news, research and original financial content. Learn about investing in stocks and sector trends with our news alerts, articles, podcasts and videos, looking at cannabis, crypto, AI and IoT, mining, sports biotech, water, renewable energy and more. Investor Idea’s original branded content includes the following podcasts and columns : Crypto Corner , Play by Play sports and stock news column, Investor Ideas Potcasts Cannabis News and Stocks on the Move podcast and column, Cleantech and Climate Change , Exploring Mining the AI Eye .
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions. More disclaimer info:
https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com
Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp
Investor Ideas does not condone the use of cannabis except where permissible by law. Our site does not possess, distribute, or sell cannabis products.
Follow us on Social Media
Contact Investorideas.com
800-665-0411
